Publicacions en què col·labora amb MARÍA JOSÉ ZARZUELO ROMERO (75)

2023

  1. Innovación docente en farmacología: relato de nuestra experiencia en el aprendizaje basado en artefactos (ABA)

    Actualidad en farmacología y terapéutica, Vol. 21, Núm. 2, pp. 150-163

2015

  1. A new therapeutic association to manage relapsing experimental colitis: Doxycycline plus Saccharomyces boulardii

    Pharmacological Research, Vol. 97, pp. 48-63

  2. Antihypertensive effects of probiotics Lactobacillus strains in spontaneously hypertensive rats

    Molecular Nutrition and Food Research, Vol. 59, Núm. 11, pp. 2326-2336

  3. Chronic peroxisome proliferator-activated receptorβ/δ agonist GW0742 prevents hypertension, vascular inflammatory and oxidative status, and endothelial dysfunction in diet-induced obesity

    Journal of Hypertension, Vol. 33, Núm. 9, pp. 1831-1844

2014

  1. Chronic hydroxychloroquine improves endothelial dysfunction and protects kidney in a mouse model of systemic lupus erythematosus

    Hypertension, Vol. 64, Núm. 2, pp. 330-337

  2. Intestinal anti-inflammatory activity of the polyphenolic-enriched extract Amanda® in the trinitrobenzenesulphonic acid model of rat colitis

    Journal of Functional Foods, Vol. 11, Núm. C, pp. 449-459

  3. Intestinal anti-inflammatory effects of oligosaccharides derived from lactulose in the trinitrobenzenesulfonic acid model of rat colitis

    Journal of Agricultural and Food Chemistry, Vol. 62, Núm. 19, pp. 4285-4297

2013

  1. Active colitis exacerbates immune response to internalized food antigens in mice

    International Archives of Allergy and Immunology, Vol. 162, Núm. 3, pp. 214-224

  2. Intestinal anti-inflammatory activity of hydroalcoholic extracts of Phlomis purpurea L. and Phlomis lychnitis L. in the trinitrobenzenesulphonic acid model of rat colitis.

    Journal of Ethnopharmacology, Vol. 146, Núm. 3, pp. 750-759

  3. Minocycline: Far beyond an antibiotic

    British Journal of Pharmacology, Vol. 169, Núm. 2, pp. 337-352

  4. What is behind the non-antibiotic properties of minocycline?

    Pharmacological Research, Vol. 67, Núm. 1, pp. 18-30

2012

  1. A shorter and more specific oral sensitization-based experimental model of food allergy in mice

    Journal of Immunological Methods, Vol. 381, Núm. 1-2, pp. 41-49

  2. The immunomodulatory properties of viable Lactobacillus salivarius ssp. salivarius CECT5713 are not restricted to the large intestine

    European Journal of Nutrition, Vol. 51, Núm. 3, pp. 365-374

  3. The intestinal anti-inflammatory effect of dersalazine sodium is related to a down-regulation in IL-17 production in experimental models of rodent colitis

    British Journal of Pharmacology, Vol. 165, Núm. 3, pp. 729-740

2011

  1. Antihypertensive effects of peroxisome proliferator-activated receptor-β activation in spontaneously hypertensive rats

    Hypertension, Vol. 58, Núm. 4, pp. 733-743

  2. DNFB-DNS hapten-induced colitis in mice should not be considered a model of inflammatory bowel disease

    Inflammatory Bowel Diseases, Vol. 17, Núm. 10, pp. 2087-2101

  3. The association of minocycline and the probiotic Escherichia coli Nissle 1917 results in an additive beneficial effect in a DSS model of reactivated colitis in mice

    Biochemical Pharmacology, Vol. 82, Núm. 12, pp. 1891-1900

  4. The intestinal anti-inflammatory effect of minocycline in experimental colitis involves both its immunomodulatory and antimicrobial properties

    Pharmacological Research, Vol. 63, Núm. 4, pp. 308-319

2010

  1. Butyrate in vitro immune-modulatory effects might be mediated through a proliferation-related induction of apoptosis

    Immunobiology, Vol. 215, Núm. 11, pp. 863-873

  2. Di-D-fructose dianhydride-enriched caramels: Effect on colon microbiota, inflammation, and tissue damage in trinitrobenzenesulfonic acid-induced colitic rats

    Journal of Agricultural and Food Chemistry, Vol. 58, Núm. 10, pp. 6476-6484